We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Evotec SE (PK) | USOTC:EVOTF | OTCMarkets | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 8.98 | 8.56 | 9.34 | 0.00 | 21:12:43 |
From Jun 2019 to Jun 2024
FRANKFURT (Dow Jones)--Evotec AG (EVT.XE) and German pharmaceutical and chemical company Merck KGaA will collaborate on an undisclosed neurological disease, Evotec said in a statement Tuesday.
MAIN FACTS:
-The companies will develop pre-clinical candidates for the neurological disease.
-The project is partially funded by the Federal Ministry of Education and Research.
-Frankfurt Bureau, Dow Jones Newswires; 49-69-29725-500
1 Year Evotec (PK) Chart |
1 Month Evotec (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
